Synovus price target raised to $37 from $29 at Morgan Stanley

Morgan Stanley analyst Manan Gosalia raised the firm’s price target on Synovus (SNV) to $37 from $29 and keeps an Equal Weight rating on the shares. The events in the past week at New York Community Bancorp (NYCB) don’t change the firm’s view that working through CRE will be a long grind for the group, but with weakness accelerating for the next two to three quarters, adds the analyst, who remains In-Line on midcap banks with a skew to defensive names. For the midcap group, the firm is increasing price targets by a median 20% as it rolls its valuation year from 2024 to 2025.